MarketPulse
O

$OLMA

2 articles found
1 positive
1 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Olema Oncology Advances Breast Cancer Pipeline, Secures $218.5M in Funding

Olema reported strong trial progress for palazestrant in breast cancer, raised $218.5M, and expects pivotal data in fall 2026.
PFEOLMAPhase 3 trialsclinical development
BenzingaBenzinga··Business Wire

OLMA Stock Plummets 19.6% Amid Securities Investigation Over Undisclosed Trial Risks

DJS Law Group investigates Olema Pharmaceuticals for potential securities violations following failed Roche trial, triggering sharp stock decline.
OLMAstock declinemisleading statements